Not applicableNo Longer AvailableNCT01871233What this trial is testingAn Extended Access Program for PerampanelWho this might be right forPartial Onset Seizures Eisai Inc.
Not applicableUnknownNCT05278221What this trial is testingTMS Combined With EEG/EMG as a Biomarker Predicting Antiepileptic Drug ResponseWho this might be right forFocal Epilepsy Aristotle University Of Thessaloniki 42
Not applicableEnded earlyNCT01462656What this trial is testingRisk of Urinary Retention With RetigabineWho this might be right forEpilepsy GlaxoSmithKline 1
Post-approval studies (Phase 4)UnknownNCT00647322What this trial is testingThe Impact of Reducing Overtreatment on Quality of Life in Children With Refractory EpilepsyWho this might be right forIntractable Epilepsy Institute of Child Health 64
Not applicableUnknownNCT04043572What this trial is testingThe Biomarkers of Neurological Disease in Utero StudyWho this might be right forEpilepsyNeurodevelopmental DisordersFetal Disease+1 more Nottingham University Hospitals NHS Trust 20
Post-approval studies (Phase 4)Study completedNCT00006395What this trial is testingDrug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal VolunteersWho this might be right forHealthy National Institutes of Health Clinical Center (CC) 12
Not applicableStudy completedNCT00144001What this trial is testingFactors Associated With in Suboptimal Prescribing for Older Patients With EpilepsyWho this might be right forEpilepsy US Department of Veterans Affairs 9,682
Post-approval studies (Phase 4)Study completedNCT01630057What this trial is testingEvaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic DrugWho this might be right forPartial Seizures Eisai Inc. 200
Early research (Phase 1)Study completedNCT00736931What this trial is testingClinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamWho this might be right forEpilepsy UCB Pharma 20
Post-approval studies (Phase 4)Study completedNCT00043914What this trial is testingMeasurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With EpilepsyWho this might be right forEpilepsy GlaxoSmithKline 72
Post-approval studies (Phase 4)UnknownNCT00133081What this trial is testingStudy to Improve the Treatment of Epilepsy (SITE)Who this might be right forEpilepsy UMC Utrecht 255
Early research (Phase 1)Study completedNCT02132897What this trial is testingFed Bioequivalence Study of CBZ FormulationsWho this might be right forBio-equivalence StudyFed Conditions Center for Clinical Pharmacology Research Bdbeq S.A. 20
Not applicableStudy completedNCT01390909What this trial is testingClinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan DatabaseWho this might be right forEpilepsy GlaxoSmithKline 12,386
Not applicableStudy completedNCT02556320What this trial is testingImmunological and Viral Parameters in Patients Receiving Anti-epileptic DrugsWho this might be right forEpilepsyDrug Hypersensitivity Syndrome University Hospital, Rouen 30
Post-approval studies (Phase 4)Study completedNCT00153283What this trial is testingStudy of Efficacy of Gabapentin in Therapy of Bronchial AsthmaWho this might be right forBronchial Asthma Centre of Chinese Medicine, Georgia 68
Large-scale testing (Phase 3)Study completedNCT01806805What this trial is testingEfficacy Trial of Zonisamide for Myoclonus DystoniaWho this might be right forMyoclonus Dystonia Assistance Publique - Hôpitaux de Paris 24
Not applicableStudy completedNCT02993861What this trial is testingPharmacokinetics of Anti-epileptic Drugs in Obese ChildrenWho this might be right forEpilepsyObese Christoph P Hornik, MD MPH 106
Large-scale testing (Phase 3)Study completedNCT01227902What this trial is testingStudy of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset SeizuresWho this might be right forEpilepsy GlaxoSmithKline 203
Testing effectiveness (Phase 2)Study completedNCT03694275What this trial is testingA Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)Who this might be right for15q Duplication SyndromeCDKL5 Deficiency Disease Takeda 20
Not applicableStudy completedNCT01991041What this trial is testingEuropean Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS)Who this might be right forLennox-Gastaut Syndrome Eisai Limited 109